19 Oct. 2026

Post-doctoral fellow (Cancer Dormancy & Immunity Lab)

Research
Application Starts: 19 Oct. 2026

 

The Cancer Dormancy & Immunity Lab headed by Ana Luísa Correia is seeking a highly motivated postdoctoral candidate
to join us on a project supported by an AACR Trailblazer grant.

15 October 2026

Over €1.25 million awarded to three Champalimaud Foundation researchers for neuroscience and immunology

The three projects span very different areas of research. Moita, working in partnership with César Mendes at NOVA Medical School, will investigate how the brain and body produce the rapid defensive reactions that make us jump or flinch when startled. Van Gisbergen will study how certain immune cells establish themselves in the lungs, with the long-term goal of improving vaccines against influenza and other respiratory viruses.

12 October 2026

When "mild" isn't mild: Champalimaud Foundation surgeons propose a new way to grade bleeding after pancreatic surgery

Surgery is often the main treatment for pancreatic cancer and for several other pancreatic conditions. It is also one of the most complex surgical operations in medicine. A particularly feared complication afterwards is internal bleeding, known as postpancreatectomy haemorrhage. Since 2007, surgeons worldwide have graded these bleeds with an international system. It combines three factors: when the bleeding starts, where it happens and how severe it seems.

08 October 2026

Champalimaud Foundation’s surgeons take on pancreatic cancer’s ‘invisible’ enemy, in the OR and in the bloodstream

A small “triangle” with a big impact

Behind the pancreas lies a compact, triangle‑shaped area bordered by three major blood vessels that supply the abdomen. Surgeons call it the TRIANGLE compartment. In standard pancreatic cancer surgery, this region is not systematically removed. For years, however, specialists have suspected that microscopic cancer cells may be hiding there, beyond what imaging and the naked eye can detect.

02 October 2026

Science can be tasted, too

There is a line by British artist David Shrigley that goes: “I had no interest in it then I looked inside and now I'm enchanted by it.” In other words, it is difficult to be genuinely interested in something we know nothing about. First, we need the chance to take a look inside. To get closer. To explore. To ask questions. And sometimes, it is at that very moment, when something that once seemed distant becomes tangible, that fascination begins.
The same is true of science.

Translational advances in multiple myeloma: β-adrenergic blockade and strategies to overcome metabolite-driven resistance to BCL-2 antagonists

 Host

Cristina João, MD, PhD, Myeloma Lymphoma Lab


Venue

Seminar Room

01 October 2026

Turning patients' words into better care: Europe launches ResPECT AI assistant

Millions of people living with Breast cancer or depression experience physical, psychological, social and financial burdens that remain unseen or insufficiently addressed in routine care. Although patient-reported outcome measures exist and provide valuable insights, they often reduce complex patient experiences to numerical scores. At the same time, healthcare professionals face fragmented clinical data, increasing documentation demands and digital tools that are not always well integrated into care.

Curso Breve de Psicofarmacologia em Oncologia

Data

22 – 23 Janeiro 2027

Localização

Seminar Room, Fundação Champalimaud, Lisboa 

In search of good memory: from germinal centers to CNS circuits

Host

Henrique Veiga-Fernandes, PhD, Immunophysiology Lab


Venue

Seminar Room


Abstract

TBD

Outubro Rosa 2026

Sobre a participação da Fundação Champalimaud

Em outubro, iremos reunir conhecimento, investigação e cuidados de saúde para promover uma abordagem cada vez mais integrada e personalizada ao cancro da mama. Convidamos-vos a conhecer melhor o que fazemos, como investigamos e de que forma estamos a trabalhar para um futuro com mais prevenção, melhores tratamentos e maior qualidade de vida. Juntem-se a nós para partilhar, debater e apoiar.

Idioma

Este programa será conduzido em português.

Subscribe to Cancer
Loading
Please wait...